AI Innovation Unlocks Non-Surgical Way to Detect Brain Cancer Spread

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery.

The proof-of-concept study, co-led by McGill University researchers Dr. Matthew Dankner and Dr. Reza Forghani, alongside an international team of clinicians and scientists, demonstrated the AI model can detect the presence of cancer cells in surrounding brain tissue with 85-per-cent accuracy.

Researchers tested the model using MRI scans from over 130 patients who had surgery to remove brain metastases at The Neuro (Montreal Neurological Institute-Hospital). They validated the AI’s accuracy by comparing its results to what doctors observed in the tumour tissue under a microscope.

Brain metastases, the most common type of brain cancer, occur when cancer cells from other parts of the body spread to the brain. These tumours can be particularly aggressive when invasive cancer cells grow into surrounding healthy brain tissue, making them harder to treat.

"Our previous research found that invasive brain metastases are linked to shorter survival and a higher risk of tumour regrowth. These findings demonstrate the enormous potential of machine learning to soon improve our understanding of cancer and its treatment," said Dankner, an Internal Medicine Resident at McGill and post-doctoral researcher at the Rosalind & Morris Goodman Cancer Institute.

The AI model detects subtle changes in the surrounding brain tissue that indicate cancer has spread, spotting patterns often too faint for traditional imaging methods that rely on human interpretation. It was developed by Forghani’s lab during his time at the Research Institute of the McGill University Health Centre and the University of Florida College of Medicine.

Earlier this year, the researchers identified drugs that could potentially treat some brain metastases. However, to determine which patients may ultimately benefit from this approach, doctors need to know whether the cancer has spread into the surrounding tissue. Surgery is the most common solution, but it isn’t always an option for patients, especially if their tumours are hard to reach or their health makes surgery too risky.

"With further development, our AI model could become a part of clinical practice, which can help us catch cancer spread within the brain earlier and more accurately," said Dr. Benjamin Rehany, a Radiology Resident at the University of Toronto and one of the primary authors of the publication.

While their work is still in the early stages, the researchers plan to expand the study with larger datasets and refine the AI model for clinical use.

The research was supported by the Canadian Cancer Society, the Canadian Institutes of Health Research, the Brain Canada Foundation, Health Canada, Fonds de recherche du Québec - Santé, and the Fondation de l’Association des radiologistes du Québec.

Najafian K, Rehany B, Nowakowski A, Ghazimoghadam S, Pierre K, Zakarian R, Al-Saadi T, Reinhold C, Babajani-Feremi A, Wong JK, Guiot MC, Lacasse MC, Lam S, Siegel PM, Petrecca K, Dankner M, Forghani R.
Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scans.
Neurooncol Adv. 2024 Nov 16;6(1):vdae200. doi: 10.1093/noajnl/vdae200

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...